[Tetracyclines, sulfonamides and metronidazole]

Area of Science:

• Microbiology and Pharmacology
• Antimicrobial Agents
• Bacterial Protein Synthesis Inhibition

Background:

• Tetracyclines are bacteriostatic antibiotics inhibiting bacterial protein synthesis, with doxycycline being a key example in human medicine.
• Acquired resistance has limited the use of tetracyclines, despite their broad-spectrum activity.
• Sulfonamides, early systemic antimicrobials, inhibit DNA synthesis but have limited current use due to toxicity and resistance.

Purpose of the Study:

• To review the properties and current utility of tetracyclines, sulfonamides, and metronidazole.
• To highlight the impact of acquired resistance and toxicity on antibiotic பயன்பாடு (usage).
• To underscore the continued importance of certain antibiotics like doxycycline and metronidazole.

Main Methods:

• Literature review of antibiotic classes: tetracyclines, sulfonamides, and 5-nitroimidazoles.
• Analysis of mechanisms of action, spectrum of activity, and resistance patterns.
• Evaluation of clinical relevance and current therapeutic applications.

Main Results:

• Doxycycline remains a frequently used tetracycline, listed as an essential medicine.
• Sulfonamides exhibit broad-spectrum activity but are infrequently used due to resistance and toxicity.
• Metronidazole is highly effective against anaerobic bacteria and parasitic infections.

Conclusions:

• Despite challenges like resistance, doxycycline remains a vital antibiotic.
• Metronidazole continues to be a crucial treatment for specific bacterial and parasitic infections.
• The clinical utility of sulfonamides is significantly diminished.